The RUNX1–ALSF Early Career Investigator Grant 2027 provides up to US$180,000 over three years for research on preventing blood cancer in people with RUNX1 familial platelet disorder (RUNX1-FPD). The RUNX1 Research Program and Alex’s Lemonade Stand Foundation (ALSF) jointly support the grant.
The programme funds basic and translational studies that investigate how to prevent progression from a premalignant state to blood cancer. It is open to eligible investigators at nonprofit institutions worldwide.
Eligibility Criteria
- Applicants must hold an MD, PhD, MD/PhD or equivalent degree.
- Applicants at assistant professor level or equivalent must be within five years of their first tenure-track appointment. Associate and full professors are ineligible.
- Instructor-level applicants need mentor support.
- Applicants must be based at a nonprofit institution. U.S. citizenship is not required.
- Applicants must have at least 75% protected time for research overall and relevant expertise in blood cell development, immunology or both.
Funding Details
- Maximum award: US$180,000 over three years, capped at US$60,000 per year.
- Eligible costs: Direct costs only. Indirect costs are not permitted.
- Continued funding: Subject to satisfactory progress and appropriate expenditure.
Deadline
- Application deadline: December 17, 2026, at 8:00 p.m. U.S. Eastern Time.
- Award notification: May 2027, according to the foundation’s current grants calendar.